Search clinical trials for: Bosentan administration

Total 3336 results

VA Loma Linda Health Care System
Actelion

Completed

Effect of Bosentan on Exercise Capacity at High Altitude

Pulmonary Hypertension | Altitude

United States
Competence Network for Congenital Heart Defects
German Federal Ministry of Education and Research; Actelion

Completed

Bosentan in Treatment of Pulmonary Arterial Hypertension

Eisenmenger Syndrome

Germany
Assistance Publique - Hôpitaux de Paris

Completed

Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia

Hypoxia-Induced Pulmonary Artery Hypertension

France
Universitair Ziekenhuis Brussel

Completed

Transcranial Doppler in Multiple Sclerosis (TRADOMS)

Multiple Sclerosis

Belgium
Vivatech

Completed

Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles Disorders (Easykrill)

Pain

France
Actelion

Completed

Bosentan in Digital Ulcers (RAPIDS 2 OL)

Digital Ulcers

France, United Kingdom, United States, Austria, Canada, Germany, Italy, Switzerland
Geropharm

Completed

Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects

Bioequivalence

Russian Federation
Actelion

Completed

Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma (RAPIDS-2)

Systemic Sclerosis | Digital Ulcers

United States, Canada
Actelion

Completed

Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (BENEFIT OL)

Pulmonary Hypertension

United States, Canada, Australia, Germany, Italy, United Kingdom, France, Austria, Belgium, Czech Republic, Netherlands, Poland, Spain
Medical University of Vienna

Completed

Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma

Glaucoma | Blood Flow Velocity

Austria
Actelion

Completed

Open-label Study With Bosentan in Interstitial Lung Disease (BUILD 2 OL)

Interstitial Lung Disease | Scleroderma

United States, Korea, Republic of, Israel, France, United Kingdom, Netherlands, Switzerland, Germany, Canada, Italy, Sweden
General Hospital of Chalkida

Unknown

Bosentan for Severe Mitral Valve Dysfunction (BOSMIVAR)

SECONDARY PULMONARY HYPERTENSION | MITRAL STENOSIS | CHILDHOOD RHEUMATOID FEVER | CONGESTIVE HEART FAILURE

Greece
Rikshospitalet University Hospital

Terminated

Treatment of Early Systemic Sclerosis by Bosentan (TRANOS)

Systemic Sclerosis (Scleroderma)

Norway
Actelion

Completed

Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

Canada, United Kingdom, Italy, United States, Netherlands, Australia, Austria, Belgium, France, Germany, Spain
Elpen Pharmaceutical Co. Inc.

Completed

Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis (GRegistry SCDU)

Scleroderma | Digital Ulcer | Systematic Sclerosis

Greece
University Medical Center Groningen
Actelion

Completed

The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis (CEASESTIFF)

Scleroderma, Systemic

Netherlands
Berto J Bouma

Unknown

Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery (BOCA)

Congenital Heart Disease

Netherlands
Actelion

Completed

Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Canada, Australia, Germany, United States, Italy, United Kingdom, Austria, Belgium, Czech Republic, France, Netherlands, Poland, Spain
Heinrich-Heine University, Duesseldorf

Completed

Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis

Systemic Scleroderma | Skin Fibrosis | Hand Functionality

Germany
University Hospital, Grenoble

Recruiting

ENDOTHELION Study Group: Effect of Bosentan in NAION Patients (ENDOTHELION)

Ischemic Optic Neuropathy

France
Daniel Doberer

Terminated

Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis (BOPSAC)

Pulmonary Hypertension | Sarcoidosis

Austria
Actelion

Terminated

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH) (ASSET-2)

Pulmonary Hypertension

United States, France, United Kingdom, Netherlands
Hamilton Health Sciences Corporation
Actelion

Unknown

A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Hypertension, Pulmonary | Connective Tissue Disease

Canada
Rajan Saggar
Actelion

Withdrawn

Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan

Idiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension

United States
Actelion

Completed

Pulmonary Artery Remodelling With Bosentan

Hypertension, Pulmonary

Australia
UConn Health
Actelion

Terminated

Bosentan for Poorly Controlled Asthma

Asthma

United States
Medical University of Vienna

Terminated

Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis

Liver Cirrhosis | Hepatopulmonary Syndrome

Austria
Actelion

Completed

The Effect of Tracleer® on Male Fertility

Hypertension, Pulmonary

United States, Australia, Brazil, Czech Republic, Hungary
Rigshospitalet, Denmark
Aarhus University Hospital; Bispebjerg Hospital; Actelion

Completed

Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology. (TEMPO)

Tricuspid Atresia | Hypoplastic Left Heart Syndrome | Other Specified Congenital Anomalies of Heart

Denmark, Sweden
University Teaching Hospital Hall in Tirol

Completed

Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension (BADDHY)

Hypertension, Pulmonary | Heart Failure, Diastolic

Austria
Universitaire Ziekenhuizen KU Leuven

Completed

Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. (BOMPA)

Heart Septal Defects, Atrial

Belgium
Actelion

Completed

Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension (FUTURE 3)

Pulmonary Arterial Hypertension

United States, Australia, Belarus, China, Czechia, France, Germany, Hungary, India, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine
Actelion

Completed

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis (BUILD 1)

Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Switzerland, Israel, Canada, France, Germany, Italy
Actelion

Completed

Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II

Pulmonary Hypertension

United States, Netherlands, Canada, Spain, China, Belgium, Germany, Italy, United Kingdom, Switzerland, Australia, Austria, Czech Republic, France
Centre hospitalier de l'Université de Montréal...
Actelion

Terminated

Bosentan Use in Patients With Diabetic Nephropathy

Type 2 Diabetes

Canada
Actelion

Completed

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) (Compass-2)

Pulmonary Arterial Hypertension

United States, Denmark, Sweden, Germany, Spain, Brazil, Saudi Arabia, Portugal, Greece, Slovakia, United Kingdom, Czech Republic
Hanmi Pharmaceutical Company Limited

Completed

To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers

Pulmonary Arterial Hypertension

Korea, Republic of
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Actelion

Completed

Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea (BOSAS)

Hypertension | Obstructive Sleep Apnea

France
University Medical Center Groningen
Erasmus Medical Center

Completed

Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging (TARGET)

Papillary Thyroid Cancer | Lymph Node Metastases

Netherlands
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

Healthy

Germany
Bial - Portela C S.A.

Completed

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

Pulmonary Arterial Hypertension

Germany
Dong-A Pharmaceutical Co., Ltd.
Dong-A ST Co., Ltd.

Unknown

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration

Healthy Volunteers

Korea, Republic of
West Penn Allegheny Health System
Johns Hopkins University; University of Colorado, Denver; Massachusetts General... and other collaborators

Withdrawn

Pharmacogenomics in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension | Pulmonary Hypertension | PAH WHO Group I

United States
Stanford University

Terminated

Insulin Resistance in Pulmonary Arterial Hypertension

Hypertension, Pulmonary

United States
Aura Biosciences

Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Muscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder Cancer

United States
BiondVax Pharmaceuticals ltd.

Completed

A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

Healthy | Influenza

Israel
GlaxoSmithKline

Recruiting

BENLYSTA® Special Drug Use Investigation

Systemic Lupus Erythematosus

Japan
Rigshospitalet, Denmark

Completed

Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome

Eisenmenger Syndrome

Denmark
Assistance Publique - Hôpitaux de Paris
Actelion

Completed

Effect of Bosentan in Scleroderma Renal Crisis (ScS-REINBO)

Scleroderma Renal Crisis

France
Actelion

Completed

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Scleroderma, Systemic | Pulmonary Fibrosis

United States, Israel, France, United Kingdom, Netherlands, Switzerland, Germany, Italy, Sweden

Search clinical trials for: Bosentan administration

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations